Cargando…
FTO‐mediated m(6)A modification of SOCS1 mRNA promotes the progression of diabetic kidney disease
Autores principales: | Sun, Qiang, Geng, Houfa, Zhao, Meng, Li, Yang, Chen, Xi, Sha, Qian, Lai, Peng, Tang, Daoquan, Yang, Dongzhi, Liang, Jun, Guo, Mengzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217105/ https://www.ncbi.nlm.nih.gov/pubmed/35731980 http://dx.doi.org/10.1002/ctm2.942 |
Ejemplares similares
-
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
por: Qin, Bo, et al.
Publicado: (2022) -
METTL3 Is Involved in the Development of Graves’ Disease by Inducing SOCS mRNA m6A Modification
por: Song, Rong-hua, et al.
Publicado: (2021) -
FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation
por: Ding, Yudi, et al.
Publicado: (2020) -
FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA
por: Gan, Xiaojie, et al.
Publicado: (2022) -
N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability
por: Zou, Libin, et al.
Publicado: (2022)